...
首页> 外文期刊>Heart >β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study
【24h】

β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study

机译:急性心肌梗死后有心力衰竭临床证据的患者的β受体阻滞剂治疗及其他预后变量:来自AIRE研究的证据

获取原文
获取原文并翻译 | 示例

摘要

To examine clinical outcomes associate with optional βblockade in a population of patients with evident of heart failure after myocardial infarction. Design and patients-Data from the acute Infarction ramipril efficacy (AIRE) study Were analysed retrospectively. At baseline 22.3/100 of the patients were receiving a βblocker.
机译:为了检查在患有心肌梗塞后心力衰竭的患者人群中的临床结局与可选的β阻滞剂相关。回顾性分析设计和患者-急性雷米普利有效性(AIRE)研究的数据。在基线时,22.3 / 100的患者正在接受β受体阻滞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号